RSS Feed
December 29th, 2011 
FAKE NEWS for the Zionist agenda Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their disease from worsening for only a few months, with more side effects.
Related posts:
Kidney transplant patients seek life without drugs
EU OKs Novartis drug Signifor for Cushing's disease
Isentress Approval Expanded to Include Children and Teens
Fed judge considers if pharmacies must sell Plan B
Long-Term Salty Diets Tied Again to High Blood Pressure
World cancer cases to rise by 75 percent by 2030
Posted in 
Tags: 
